MPC Intramyocardial injection

BIOLOGICAL2 trials

Sponsors

Deborah Ascheim, Annetine Gelijns

Conditions

CardiomyopathyHeart FailureVentricular Dysfunction

Phase 2

The Effect of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in Patients Undergoing LVAD Implantation

CompletedNCT01442129

Deborah AscheimCardiomyopathy, Heart Failure, Ventricular Dysfunction

Start: 2012-04-30End: 2013-08-31Updated: 2015-05-01

Safety & Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients

CompletedNCT02362646

Annetine GelijnsCardiomyopathy, Heart Failure, Ventricular Dysfunction

Start: 2015-07-31End: 2019-08-23Updated: 2019-11-26

Related Papers

Intramyocardial Injection of Mesenchymal Precursor Cells and Successful Temporary Weaning From Left Ventricular Assist Device Support in Patients With Advanced Heart Failure

JAMA2019-03-26109 citations

Mesenchymal Precursor Cells as Adjunctive Therapy in Recipients of Contemporary Left Ventricular Assist Devices

Circulation2014-03-29172 citations